10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-289.55%
Negative EBIT growth while ITRG is at 100.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-289.55%
Negative operating income growth while ITRG is at 24.56%. Joel Greenblatt would press for urgent turnaround measures.
-72.32%
Negative net income growth while ITRG stands at 2.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-75.00%
Negative EPS growth while ITRG is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-75.00%
Negative diluted EPS growth while ITRG is at 9.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.63%
Share reduction while ITRG is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-571.76%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-397.57%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
84.24%
Positive long-term OCF/share growth while ITRG is negative. John Neff would see a structural advantage in sustained cash generation.
87.21%
5Y OCF/share CAGR at 75-90% of ITRG's 99.42%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-174.49%
Negative 3Y OCF/share CAGR while ITRG stands at 98.91%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
96.83%
Similar net income/share CAGR to ITRG's 99.44%. Walter Schloss would see parallel tailwinds or expansions for both firms.
71.57%
5Y net income/share CAGR at 75-90% of ITRG's 91.60%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-92.44%
Negative 3Y CAGR while ITRG is 95.32%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-98.24%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-92.26%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-80.46%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.61%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-9.52%
We have a declining book value while ITRG shows 0.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
289.27%
We expand SG&A while ITRG cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.